Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

IntroductionVaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an effective way of protecting individuals from severe coronavirus disease 2019 (COVID-19). However, immune responses to vaccination vary considerably. This study dynamically assessed the neutra...

Full description

Bibliographic Details
Main Authors: Yi Wang, Jianhua Li, Wenhui Zhang, Shourong Liu, Liangbin Miao, Zhaoyi Li, Ai Fu, Jianfeng Bao, Lili Huang, Liping Zheng, Er Li, Yanjun Zhang, Jianhua Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
inactivated COVID-19 vaccination
dosing interval
neutralizing antibody
seroconversion
people living with HIV
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1152695/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1152695/full

Similar Items